CEO Todd Sherer, PhD, talks to Dave Iverson about why levodopa loses efficacy over time and new therapies in development to even out on/off cycles.
Mentioned in this episode:
From now through December 2, you can help accelerate Parkinson’s research. This Giving Tuesday, all donations to The Michael J. Fox Foundation will be matched up to $4 million, which means your impact will be doubled. Visit michaeljfox.org/givetoresearch to be part of the cure.
